The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knox, P. G.
Right arrow Articles by Young, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knox, P. G.
Right arrow Articles by Young, L. S.
The Journal of Immunology, 2003, 170: 677-685.
Copyright © 2003 by The American Association of Immunologists

Inhibition of Metalloproteinase Cleavage Enhances the Cytotoxicity of Fas Ligand1

Pauline G. Knox, Anne E. Milner, Nicky K. Green, Aristides G. Eliopoulos and Lawrence S. Young2

Cancer Research United Kingdom Institute for Cancer Studies, University of Birmingham Medical School, Edgbaston, Birmingham B15 2TT, United Kingdom

The Fas ligand (FasL)/Fas receptor (CD95) pathway is an important mediator of apoptosis in the immune system and can also mediate cancer cell death. Soluble FasL (sFasL), shed from the membrane-bound form of the molecule by a putative metalloproteinase (MP), may function to locally regulate the activity of membrane-bound FasL. Using a replication-defective recombinant adenovirus-expressing FasL (RAdFasL), we identified a variable ability of different carcinoma cells to respond to FasL-induced cytotoxicity and to shed sFasL. Blockade of FasL cleavage with an MP inhibitor significantly enhanced RAdFasL-induced apoptosis suggesting that sFasL may antagonize the effect of membrane-bound FasL. In support of this concept, a recombinant adenovirus expressing a noncleavable form of FasL (RAdD4) was found to be a potent inducer of apoptosis even at very low virus doses. Our results highlight the therapeutic potential of noncleavable FasL as an antitumor agent and emphasize the important role of MP via the production of sFasL in regulating the response of the Fas pathway. Moreover, these findings have general implications for the therapeutic exploitation of TNF family ligands and for the possible impact of MP-based therapies on the normal physiology of Fas/TNF pathways.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
A. Orbach, J. Rachmilewitz, M. Parnas, J.-H. Huang, M. L. Tykocinski, and M. Dranitzki-Elhalel
CTLA-4 {middle dot} FasL Induces Early Apoptosis of Activated T Cells by Interfering with Anti-Apoptotic Signals
J. Immunol., December 1, 2007; 179(11): 7287 - 7294.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Giustiniani, A. Marie-Cardine, and A. Bensussan
A Soluble Form of the MHC Class I-Specific CD160 Receptor Is Released from Human Activated NK Lymphocytes and Inhibits Cell-Mediated Cytotoxicity
J. Immunol., February 1, 2007; 178(3): 1293 - 1300.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
W. Baum, V. Kirkin, S. B. M. Fernandez, R. Pick, M. Lettau, O. Janssen, and M. Zornig
Binding of the Intracellular Fas Ligand (FasL) Domain to the Adaptor Protein PSTPIP Results in a Cytoplasmic Localization of FasL
J. Biol. Chem., December 2, 2005; 280(48): 40012 - 40024.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A. Riccioli, V.D. Secco, P.D. Cesaris, D. Starace, L. Gandini, A. Lenzi, F. Dondero, F. Padula, A. Filippini, and E. Ziparo
Presence of membrane and soluble forms of Fas ligand and of matrilysin (MMP-7) activity in normal and abnormal human semen
Hum. Reprod., October 1, 2005; 20(10): 2814 - 2820.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. P. Mishra and C. Shaha
Estrogen-induced Spermatogenic Cell Apoptosis Occurs via the Mitochondrial Pathway: ROLE OF SUPEROXIDE AND NITRIC OXIDE
J. Biol. Chem., February 18, 2005; 280(7): 6181 - 6196.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Salerno-Goncalves, M. Fernandez-Vina, D. M. Lewinsohn, and M. B. Sztein
Identification of a Human HLA-E-Restricted CD8+ T Cell Subset in Volunteers Immunized with Salmonella enterica Serovar Typhi Strain Ty21a Typhoid Vaccine
J. Immunol., November 1, 2004; 173(9): 5852 - 5862.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. C. Davies, J. Mason, M. J. O. Wakelam, L. S. Young, and A. G. Eliopoulos
Inhibition of Phosphatidylinositol 3-Kinase- and ERK MAPK-regulated Protein Synthesis Reveals the Pro-apoptotic Properties of CD40 Ligation in Carcinoma Cells
J. Biol. Chem., January 9, 2004; 279(2): 1010 - 1019.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
O. V. Proussakova, N. A. Rabaya, A. B. Moshnikova, E. S. Telegina, A. Turanov, M. G. Nanazashvili, and I. P. Beletsky
Oligomerization of Soluble Fas Antigen Induces Its Cytotoxicity
J. Biol. Chem., September 19, 2003; 278(38): 36236 - 36241.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
U. A. Kayisli, B. Selam, O. Guzeloglu-Kayisli, R. Demir, and A. Arici
Human Chorionic Gonadotropin Contributes to Maternal Immunotolerance and Endometrial Apoptosis by Regulating Fas-Fas Ligand System
J. Immunol., September 1, 2003; 171(5): 2305 - 2313.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.